Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | 0.00% | 0.00% | +14.29% |
02/04 | Appili Therapeutics To be Acquired by Aditxt, Inc. | MT |
02/04 | Adivir, Inc. entered into a definitive agreement to acquire Appili Therapeutics Inc. for $6.7 million. | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.85M 3.55M 296M |
---|---|---|---|---|---|
Net income 2024 * | -6M -4.39M -366M | Net income 2025 * | -10M -7.31M -610M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.74
x | P/E ratio 2025 * |
-0.74
x | Employees | 9 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.94% |
Current month | +14.29% | ||
1 month | +33.33% | ||
3 months | +33.33% | ||
6 months | +14.29% | ||
Current year | +14.29% |
Managers | Title | Age | Since |
---|---|---|---|
Don Cilla
CEO | Chief Executive Officer | 63 | 01/20/01 |
Armand Balboni
CHM | Chairman | 57 | 01/18/01 |
Kenneth Howling
DFI | Director of Finance/CFO | 66 | 16/21/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 27/20/27 | |
Prakash Gowd
BRD | Director/Board Member | 60 | 13/11 |
Director/Board Member | 70 | 02/21/02 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.04 | 0.00% | 3,000 |
24/24/24 | 0.04 | 0.00% | 5,140 |
22/24/22 | 0.04 | 0.00% | 31,819 |
19/24/19 | 0.04 | +14.29% | 99,000 |
18/24/18 | 0.035 | 0.00% | 5,000 |
Delayed Quote Toronto S.E., April 26, 2024 at 08:15 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.29% | 3.54M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- APLI Stock